NDA 065290 describes CEFOTAXIME SODIUM, which is a drug marketed by
Aurobindo Pharma,
Aurobindo Pharma Ltd,
Cephazone Pharma,
Hospira,
Hospira Inc,
Lupin, and
Wockhardt, and is included in nine NDAs. Additional details are available on the
CEFOTAXIME SODIUM profile page.
The generic ingredient in CEFOTAXIME SODIUM is
cefotaxime sodium. There are fourteen
drug master file entries for this compound. One
supplier is listed for this compound. Additional details are available on the
cefotaxime sodium profile page.